2013
DOI: 10.18597/rcog.108
|View full text |Cite
|
Sign up to set email alerts
|

De la observación microscópica de los cromosomas en el cariotipo a los array-CGH en el diagnóstico prenatal

Abstract: Introducción: el cariotipo ha sido la prueba de oro para el análisis cromosómico en el diagnóstico prenatal en los últimos cuarenta años; sin embargo, a partir del 2011 se publican múltiples artículos y los primeros meta-análisis que muestran posibles ventajas de los array-CGH (del inglés array-comparative genomic hibridization) sobre el cariotipo en el diagnóstico prenatal.Objetivo: hacer una reflexión acerca del uso de array-CGH en el diagnóstico prenatal y mostrar algunas de las potenciales ventajas y desve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 17 publications
(38 reference statements)
0
1
0
Order By: Relevance
“…Array comparative genomic hybridization (aCGH) is a molecular test that evaluates the entire genome and detects numerical and structural chromosome alterations throughout all chromosomes; this diagnostic technique surpasses karyotyping by light microscopy by finding deletions and duplications up to 10,000 times smaller. The aCGH is a test used in the differential diagnosis of patients with intellectual disabilities, psychomotor development delay, autism, and multiple congenital anomalies [ 3 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…Array comparative genomic hybridization (aCGH) is a molecular test that evaluates the entire genome and detects numerical and structural chromosome alterations throughout all chromosomes; this diagnostic technique surpasses karyotyping by light microscopy by finding deletions and duplications up to 10,000 times smaller. The aCGH is a test used in the differential diagnosis of patients with intellectual disabilities, psychomotor development delay, autism, and multiple congenital anomalies [ 3 5 ].…”
Section: Introductionmentioning
confidence: 99%